Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tnfsf13em1flox/Cya
Common Name:
Tnfsf13-flox
Product ID:
S-CKO-14578
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tnfsf13-flox
Strain ID
CKOCMP-69583-Tnfsf13-B6J-VA
Gene Name
Tnfsf13
Product ID
S-CKO-14578
Gene Alias
2310026N09Rik; April; Tall2; Tnlg7b; Trdl1
Background
C57BL/6JCya
NCBI ID
69583
Modification
Conditional knockout
Chromosome
11
Phenotype
MGI:1916833
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tnfsf13em1flox/Cya mice (Catalog S-CKO-14578) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000018896
NCBI RefSeq
NM_001159505
Target Region
Exon 1~5
Size of Effective Region
~2.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Tnfsf13, also known as A proliferation-inducing ligand (APRIL), is a cytokine of the tumor necrosis factor (TNF) superfamily. It plays a crucial role in B-cell maturation, survival, proliferation, and Ig class switching [2,5,6]. It is involved in multiple signaling pathways, and its dysregulation is associated with various diseases, highlighting its biological importance. Genetic models can be used to study its function in vivo.

In human colonic epithelial cells, TNFSF13 insufficiency disrupts B-cell differentiation. TNFSF13 variant colonoids showed reduced secreted TNFSF13, increased epithelial proliferation, and reduced apoptosis. This was also confirmed in iPSC-derived colon organoids. The study identified FAS as the predominant colonic epithelial receptor for TNFSF13, and found an increase in epithelial-associated B cells in TNFSF13 variant colon tissue. Co-culture of TNFSF13 variant colonoids with memory B cells led to a reduction in IgA+ plasma cell production [1].

In hypertrophic scar, TNFSF13 was up-regulated in HS skin tissues and HSF. Recombinant TNFSF13 protein increased HSF viability, proliferation, migration, fibrosis, and inflammation by activating the NF-κB signaling pathway through interaction with HSPG2. MSC-exo alleviated HS by inhibiting the fibroblasts via the TNFSF-13/HSPG2 signaling pathway [3].

In triple-negative breast cancer, TNFSF13 upregulation correlated with a poor response to chemotherapy as it promoted autophagy initiation in chemotherapeutic-resistant TNBCs. Targeting autophagy initiation could overcome TNFSF13-related chemoresistance, suggesting TNFSF13 could be a predictive biomarker for TNBC patients receiving chemotherapy [4].

In conclusion, Tnfsf13 is essential for B-cell-related functions and is involved in multiple disease processes. Studies using gene-related models, such as the TNFSF13-variant colonoids and in vitro cell models, have revealed its role in colonic epithelial-B-cell crosstalk, hypertrophic scar formation, and chemoresistance in triple-negative breast cancer. These findings contribute to understanding the biological functions of Tnfsf13 and its implications in related diseases.

References:
1. Ma, Xianghui, Dawany, Noor, Kondo, Ayano, Kelsen, Judith R, Hamilton, Kathryn E. 2024. TNFSF13 insufficiency disrupts human colonic epithelial cell-mediated B cell differentiation. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.09.23.614260. https://pubmed.ncbi.nlm.nih.gov/39386555/
2. Dhillon, Sohita. . Telitacicept: First Approval. In Drugs, 81, 1671-1675. doi:10.1007/s40265-021-01591-1. https://pubmed.ncbi.nlm.nih.gov/34463932/
3. Zhang, Huimin, Zang, Chengyu, Zhao, Wen, Wu, Jie, Cui, Rongtao. 2023. Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway. In International journal of nanomedicine, 18, 7047-7063. doi:10.2147/IJN.S433510. https://pubmed.ncbi.nlm.nih.gov/38046235/
4. Lin, Hui-Yu, Kuei, Chia-Hao, Lee, Hsun-Hua, Chen, Chi-Long, Lin, Yuan-Feng. 2020. TNFSF13 upregulation confers chemotherapeutic resistance via triggering autophagy initiation in triple-negative breast cancer. In Journal of molecular medicine (Berlin, Germany), 98, 1255-1267. doi:10.1007/s00109-020-01952-5. https://pubmed.ncbi.nlm.nih.gov/32671412/
5. Mackay, Fabienne, Schneider, Pascal, Rennert, Paul, Browning, Jeffrey. 2001. BAFF AND APRIL: a tutorial on B cell survival. In Annual review of immunology, 21, 231-64. doi:. https://pubmed.ncbi.nlm.nih.gov/12427767/
6. Cheung, Chee Kay, Barratt, Jonathan, Lafayette, Richard, Zhang, Hong, Rizk, Dana V. 2024. Targeting APRIL in the treatment of glomerular diseases. In Kidney international, 106, 806-818. doi:10.1016/j.kint.2024.08.012. https://pubmed.ncbi.nlm.nih.gov/39182759/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest